TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation
Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening Ischemia
Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty
Monocentric Trial: Stem Cell Emergency Life Threatening Limbs Arteriopathy (SCELTA)
Effect of Cell Surface Markers and Lymphoid Cell Distribution on the Arterial Tissue Repair (ECLAR)
Intramyocardial Delivery of Autologous Bone Marrow
A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF
† Study has passed its completion date and status has not been verified in more than two years.